UPDATE: RBC Capital Markets Upgrades St. Jude Medical
January 07, 2014 at 10:38 AM EST
In a report published Tuesday, RBC Capital Markets analyst Brandon Henry upgraded St. Jude Medical (NYSE: STJ ) from Underperform to Sector Perform, raising its price target from $44.00 to $64.00. According to the report, the upgrade was based on the results of the analyst's Dec. 2013 EP survey.
